{
    "eid": "2-s2.0-84973163857",
    "title": "Effects of SULT1A1 copy number variation on estrogen concentration and tamoxifen-associated adverse drug reactions in premenopausal Thai breast cancer patients: A preliminary study",
    "cover-date": "2016-01-01",
    "subject-areas": [
        {
            "$": "Public Health",
            "@code": "2739"
        },
        {
            "$": "Oncology",
            "@code": "2730"
        },
        {
            "$": "Cancer Research",
            "@code": "1306"
        },
        {
            "$": "Epidemiology",
            "@code": "2713"
        }
    ],
    "keywords": [
        "Adverse drug reaction",
        "Breast cancer",
        "Copy number variations",
        "Estrogen",
        "SULT1A1",
        "Tamoxifen"
    ],
    "authors": [
        "Wanaporn Charoenchokthavee"
    ],
    "citedby-count": 4,
    "ref-count": 17,
    "ref-list": [
        "Tamoxifen and Ovarian Function",
        "Pharmacogenetics of anti-estrogen treatment of breast cancer",
        "Antiestrogens - Tamoxifen, SERMs and beyond",
        "The rs1800716 variant in CYP2D6 is associated with an increased double endometrial thickness in postmenopausal women on tamoxifen",
        "Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer",
        "Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism",
        "17\u00df-Hydroxysteroid dehydrogenase type 1 as predictor of tamoxifen response in premenopausal breast cancer",
        "Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients",
        "PharmGKB summary: Tamoxifen pathway, pharmacokinetics",
        "Influence of tamoxifen on sex hormones, gonadotrophins and sex hormone binding globulin in postmenopausal breast cancer patients",
        "Clinical and biomarker predictors of side effects from tamoxifen",
        "Changes in serum estrogen levels in women during tamoxifen therapy",
        "Associations of estrogen and testosterone with insulin resistance in pre- and postmenopausal women with and without hormone therapy",
        "SULT1A1, CYP2C19 and disease-free survival in early breast cancer patients receiving tamoxifen",
        "Pharmacogenomics of breast cancer therapy: An update",
        "Toxicity and adverse effects of Tamoxifen and other anti-estrogen drugs",
        "Copy number variation in sulfotransferase isoform 1A1 (SULT1A1) is significantly associated with enzymatic activity in Japanese subjects"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "Chulalongkorn University",
        "affiliation-country": "Thailand"
    },
    "funding": []
}